JETRO Startup
Global Startup Acceleration Program (GSAP) AlumnisSONIRE Therapeutics Inc.
CIC '21 Bio/Healthcare
Healthcare Manufacturing Business Products (B2B) Biotech Robotics & IoT
SONIRE has been developing the next-generation HIFU therapy system as a new treatment modality targeting at intractable cancers like pancreatic cancer using the technology and clinical know-how has been built by Tokyo Women’s Medical University, ブラック ジャック ランキングrsity and Tokyo Medical University. HIFU therapy is expected as a new cancer treatment because it is non-invasive and has no radiation risk.
Profile
- Year founded
- 10-Feb-20
- Name of the representative
- Tohru Satoh / President & CEO, Founder
- HQ location（City)
- Tokyo
- Total amount raised to date
- JPY3,100,000 / USD31.0 * updated in Mar.2023 (Unit：JPY thousand, USD mio)
- Stage
- Series B
- Major investors/VCs
- Fast Track Initiative, NISSAY CAPITAL, Nomura SPARX Investment, SBI Investment, FFG, FFG Venture Business Partners, etc.
- Partnership
- Hirata Corporation, ブラック ジャック ランキングrsity, Tokyo University of Pharmacy and Life Science
- Major Clients
CEO/Team
*The contents of this page are subject to change without prior notice. Please contact us for the latest information.
